Overview

Antiplatelet Effects of Ticagrelor Versus Clopidogrel in American Indian Patients

Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
Assess the pharmacodynamic effect of ticagrelor vs. Clopidogrel in American Indian patients with stable coronary artery disease.
Phase:
Phase 4
Details
Lead Sponsor:
Rapid City Regional Hospital, Inc
Collaborator:
AstraZeneca
Treatments:
Clopidogrel
Platelet Aggregation Inhibitors
Purinergic P2 Receptor Antagonists
Purinergic P2Y Receptor Antagonists
Ticagrelor
Ticlopidine